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Abstract 
Background: Inguinal hernia repair, gallbladder removal, and knee- and hip replacements are the most commonly 
performed surgical procedures, but all are subject to practice variation and variable patient-reported outcomes. 
Shared decision-making (SDM) has the potential to reduce surgery rates and increase patient satisfaction. This study 
aims to evaluate the effectiveness of an SDM strategy with online decision aids for surgical and orthopaedic practice 
in terms of impact on surgery rates, patient-reported outcomes, and cost-effectiveness.
Methods: The E-valuAID-study is designed as a multicentre, non-randomized stepped-wedge study in patients with 
an inguinal hernia, gallstones, knee or hip osteoarthritis in six surgical and six orthopaedic departments. The primary 
outcome is the surgery rate before and after implementation of the SDM strategy. Secondary outcomes are patient-
reported outcomes and cost-effectiveness. Patients in the usual care cluster prior to implementation of the SDM 
strategy will be treated in accordance with the best available clinical evidence, physician’s knowledge and preference 
and the patient’s preference. The intervention consists of the implementation of the SDM strategy and provision of 
disease-specific online decision aids. Decision aids will be provided to the patients before the consultation in which 
treatment decision is made. During this consultation, treatment preferences are discussed, and the final treatment 
decision is confirmed. Surgery rates will be extracted from hospital files. Secondary outcomes will be evaluated using 
questionnaires, at baseline, 3 and 6 months.
Discussion: The E-valuAID-study will examine the cost-effectiveness of an SDM strategy with online decision aids 
in patients with an inguinal hernia, gallstones, knee or hip osteoarthritis. This study will show whether decision aids 
reduce operation rates while improving patient-reported outcomes. We hypothesize that the SDM strategy will lead 
to lower surgery rates, better patient-reported outcomes, and be cost-effective.
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Background
Inguinal hernia repair, gallbladder removal, and knee- 
and hip replacement are routine and elective surgeries. 
While international guidelines advocate surgery in the 
majority of patients, a wait-and-see policy is justified in 
selected cases [1–3]. Although surgery is associated with 
quick symptom relief, long term outcomes are sometimes 
less favourable [4–14]. Because of the elective nature 
of these interventions, treatment decision depends 
on multiple factors, such as the severity of symptoms, 
organizational structures, and physicians’ and patients’ 
preferences [15]. Some of these factors have a role in 
inappropriate care, unwarranted practice variation, and 
higher costs [16, 17].
Shared decision-making (SDM) leads to more appro-
priate care [18–20]. Allowing patients to have a more 
active role in their treatment decision results in a bet-
ter consultation [17]. SDM balances empirical evi-
dence, professional’s expertise and patient’s values [21]. 
In the case of SDM, clinicians need to provide patients 
with high-quality and balanced information. Clinicians 
need to assess the patients’ values and preferences, and 
assist and empower patients in their process of decision-
making [22, 23]. To support the SDM process, decision 
aids (DAs) are used. DAs are tools providing evidence-
based information on the different treatment options to 
improve the disease-specific knowledge of the patient, 
while exploring patient values [24–26]. In general, the use 
of DAs leads to better informed patients, who are able to 
select a choice of treatment based on accurate risk per-
ceptions, who can make better value-congruent choices 
and have less decisional conflict [25, 27]. The possibility 
that patients will opt for less invasive treatment choices 
will lower the costs and are potential benefits of SDM 
from a patient and societal perspective [25].
The objective of this study is to evaluate the effect of an 
SDM strategy by using online DAs, specifically designed 
for patients who are eligible for inguinal hernia repair, 
gallbladder removal, knee- or hip replacement. This study 
will compare the SDM strategy to usual care, in terms 
of surgery rates, patient-reported outcomes, and cost-
effectiveness. We hypothesize that the SDM strategy will 
reduce surgery rates, while patient-reported outcomes 
improve. The outcome of the E-valuAID-study will clar-
ify if SDM with the use of DAs is beneficial for the patient 
and our healthcare system.
Methods
The study protocol is designed in accordance with the 
CONsolidated Standards Of Reporting Trials (CON-
SORT) extension for stepped-wedge cluster randomized 
trials [28]. The study has been registered in the Nether-
lands National Trial Register (NTR) on the 22nd of Janu-
ary 2020 (Trial: NL8318, https:// www. trial regis ter. nl/ 
trial/ 8318).
Design
The E-valuAID is a multicentre, non-randomized 
stepped-wedge study in patients with an inguinal her-
nia, gallstones, knee- or hip osteoarthritis. The DAs will 
be implemented stepwise in six surgical and six ortho-
paedic departments in the Netherlands. Departments 
implement the DAs at different timepoints and will have 
different control and intervention periods. Therefore, 
Trial registration: The Netherlands Trial Register, Trial NL8318, registered 22 January 2020. URL: https:// www. trial regis ter. 
nl/ trial/ 8318.


















Clustera 1 Cb Ic I I I I I I
Cluster 2 C C I I I I I I
Cluster 3 C C C I I I I I
Cluster 4 C C C C I I I I
Cluster 5 C C C C C I I I
Cluster 6 C C C C C C I I
Fig. 1 Stepped-wedge design on hospital level (primary outcome, surgery rates). aA cluster consists of an outpatient clinic of surgery and an 
outpatient clinic of orthopaedics. bC = Control (usual care). cI = Intervention (SDM strategy with online DAs)
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the stepped-wedge design allows for comparisons 
within and between departments, and comparisons over 
time (Fig.  1). Three additional control hospitals will be 
included to investigate time trends in surgery rates for 
both surgical and orthopaedic departments across the 
entire study, without implementing DAs. Data collection 
began on July 1, 2020, and each centre will include con-
secutive eligible patients for two years (Fig. 1).
Study population
The study aims to include all patients above the age of 18 
who are referred to the outpatient clinic of participating 
departments, with one of the following conditions: an 
inguinal hernia, abdominal pain and ultrasound proven 
gallstones, knee- or hip osteoarthritis. Eligibility criteria 
are presented in Table 1. The secondary outcomes will be 
assessed in all eligible patients who agree to fill out the 
questionnaires.
Patient recruitment
Screening for eligibility will be performed by the local 
nurse practitioner, surgeon, or involved study researcher. 
Patients will be provided with information about the 
study, asked to participate, and informed consent will be 
obtained.
Outcomes
The primary outcome of the E-valuAID-study is the per-
centage of patients undergoing surgery within 6 months 
after first presentation at the outpatient clinic. Second-
ary outcomes are patient-reported outcomes and cost-
effectiveness of the SDM strategy. Figure  2 provides an 
Table 1 Eligibility criteria
Inclusion criteria Age ≥ 18 years
One of the following conditions: inguinal hernia, gallstones, knee- or hip osteoarthritis
Access to the internet
Sufficient command of the Dutch language to complete decision aids and fill out questionnaires
General exclusion criteria Current treatment for malignancy
Expected lifespan < 12 months
Pregnancy
Condition related exclusion criteria
 Inguinal hernia Recurrent or complicated inguinal hernia (e.g. incarcerated hernia, strangulation, ileus)
 Gallstones Complicated gallstone disease (e.g. cholecystitis, choledocholithiasis, biliary pancreatitis)
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Fig. 2 Clinical pathway and data collection timeline on patient level (secondary outcomes). aQ: Questionnaire. bThe definitive treatment, 
conservative or surgery, will be assessed 6 months after inclusion
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overview of the clinical pathway, data collection, and 
the timeline in which the DA and questionnaires are 
provided.
Control group
In the control group, that is before implementation of the 
SDM strategy, all participating departments will reach 
treatment decision according to usual care. Usual care 
consists of treatment decisions based on clinical infor-
mation (i.e. severity of symptoms, medical history, physi-
cal examination, and medical imaging), the physician’s 
knowledge and experience, as well as both the patient’s 
and physician’s preferences.
Intervention group
At a pre-determined timepoint illustrated in Fig.  1, the 
SDM strategy will be implemented at department level 
and the department moves to the intervention phase. 
Details on the implementation are described below. In 
the intervention phase, an online DA is provided to each 
patient before consultation in which treatment decision 
is made (Fig. 2).
The condition-specific DAs are developed in accord-
ance with the International Patient Decision Aid Stand-
ards (IPDAS) [24, 26] and in collaboration with the Dutch 
Society for Surgery (Dutch: NVvH, Nederlandse Verenig-
ing voor Heelkunde), Dutch Orthopaedic Association 
(Dutch: NOV, Nederlandse Orthopaedische Vereniging), 
the Netherlands Patients Federation (Dutch: Patiën-
tenfederatie Nederland, PFN) and medical specialists. 
All DAs are approved by the Dutch Foundation of Easy 
Reading, who judged that the content is understandable 
for most people.
The clinical content of the DAs directly reflects cur-
rent Dutch evidence-based guidelines on the treatment 
of inguinal hernia, gallstones, knee- or hip osteoarthritis 
[2, 3, 29, 30].
The DAs consist of four steps:
1. Information about the condition and treatment 
options (surgery versus wait and see).
2. A table which displays benefits, harms and probabili-
ties of outcomes of treatment options, plus a knowl-
edge questionnaire to remind about the most impor-
tant information.
3. Value clarification exercises which help the patient 
to clarify what matters most to them to decide on a 
treatment preference.
4. Reflection on responses and indicating treatment 
preference.
The layout of the DAs is displayed in Fig. 3.
Step three and four of the online DA contain a sur-
vey to assess the following information: patient’s values, 
patient’s treatment preference, and certainty about this 
preference. The patient’s values which are assessed are: 
Fig. 3 Summarized example of the DA for knee osteoarthritis, with the four corresponding steps
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concerns about surgery, concerns about complications, 
impact on daily activities, and experienced discomfort 
and pain due to the condition. Patients report their pref-
erence and their values on a slider ranging from − 5 to 
5, as illustrated in Fig. 3. A score of -5 reflects the pref-
erence for watchful waiting, and a score of 5 reflects the 
preference for surgery. A patient’s certainty about their 
treatment preference is surveyed with a similar slider, 
ranging from 0 to 10.
Implementation
Implementation of the SDM strategy is in accordance 
with a standardized protocol, which consists of four 
steps: (1) preparation, (2) instruction, (3) implementation 
of the DA and (4) evaluation.
1. During preparation, a local project group is assigned, 
including a physician, nurse practitioner, front- and 
back-office support, representative of the communi-
cation- and quality control department and the local 
project leader of the study. The group is responsible 
for setting goals, defining key results and identifying 
the clinical pathway of patients.
2. The instruction consists of 3 workshops for health-
care providers and desk employees to inform about 
SDM and to give instruction on the use of the DAs.
3. Implementation of the online DA executed by the 
local project group under supervision of the project 
leader of the study.
4. During evaluation, all stakeholders from the partici-
pating department are asked about their experiences 
with the SDM strategy.
Implementation at different departments will be per-
formed after time intervals of 3 months and within a time 
window of 2 weeks. After 18 months, all departments will 
work according to the SDM strategy, patient inclusion 
will continue for another 6  months. For an overview of 
the stepped-wedge design and implementation scheme, 
see Fig. 1.
Data collection
The primary outcome, the surgery rates within 6 months 
after first presentation at the outpatient clinic, will be 
retrieved from the electronic medical record (EMR) 
system of each hospital. Secondary outcomes will be 
retrieved from the EMR system, online questionnaires, 
and the patient-reported information assessed by the 
online DA.
EMRs will be used to extract treatment choice (sur-
gery or conservative treatment) and patient characteris-
tics (gender, age, weight, and height). Questionnaires will 
be administered online to assess secondary outcomes. 
All eligible patients will be asked to fill-out these ques-
tionnaires at three timepoints: before consultation in 
which treatment decision is made (baseline), and 3 
and 6  months after baseline. Informed consent will be 
obtained before first questionnaire and to avoid contami-
nation, the first questionnaire will be filled out before 
patients access the DA during the intervention phase.
A detailed overview of the questionnaires is summa-
rized in Table 2. Briefly, the following questionnaires will 
be used: The CollaboRATE to assess the quality of the 
decision-making process from the patient perspective 
[31], the EuroQol-5D-5L (EQ-5D-5L) for generic quality 
of life [32], the EuraHS for patients with an inguinal her-
nia [33], the Gallstone Symptom list (GSL) for patients 
with gallstones [34], the Knee injury and Osteoarthritis 
Outcome Score—Physical function Short form (KOOS-
PS) for patients with knee osteoarthritis [35], the Hip 
disability and Osteoarthritis Outcome Score—Physi-
cal function Short form (HOOS-PS) for patients with 
hip osteoarthritis [36], and the Short Form—Health and 
Labour Questionnaire (SF-HLQ) for the consequences 
of health problems [37]. Questionnaires will be provided 
online. After 1  week, patients will receive reminders by 
email up to three times to complete the questionnaires.
Sample size
Sample size calculations are based on differences in 
operation rate before and after the introduction of SDM. 
The sample size calculation is based on the formulas for 
a stepped-wedge design as proposed by Woertman et al. 
[38] Based on existing literature, the following reduction 
in surgery rate per condition is assumed: 10% for inguinal 
hernia, 10% gallstone disease, 5% for knee osteoarthritis, 
and 7% for hip osteoarthritis [39–43].
With the assumptions of a ß of 0.8, an a of 0.05 (two-
sided) and an intraclass correlation of 0.10, the estimated 
sample sizes for inguinal hernia, gallstone disease, knee- 
and hip osteoarthritis are 50, 45, 120, and 95 patients per 
department per 3  months, respectively. Total estimated 
sample sizes for inguinal hernia, gallstone disease, knee- 
and hip osteoarthritis are 2400, 2160, 5760, and 4560 
patients, respectively.
Effect evaluation
Surgery rates will be calculated at department level each 
3-month period and evaluated over time. Comparisons of 
surgery rates will be made before and after implementa-
tion of the SDM strategy.
Secondary outcomes will be compared between 
patients included before and after implementation of the 
SDM strategy.
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Cost‑effectiveness
The economic evaluation will be undertaken alongside the 
clinical study, as cost-effectiveness analysis (CEA) with 
the costs per patient at 6 months follow-up. Additionally, 
a cost-utility analysis (CUA) will be performed with the 
costs per quality-adjusted life-year (QALY) as outcome. 
Both analyses will be performed from a societal perspec-
tive, and the time horizon is set at 6 months.
Table 2 Overview of questionnaire
a Patients only receive one of these questionnaires per timepoint, depending on patient’s condition
Questionnaire Outcome measure Details Baseline 3 months 6 months
CollaboRATE [31] Level of SDM A 3-item questionnaire measuring the 
experienced level of SDM
– x –
EuroQol-5D-5L (EQ-5D-5L) [32] Quality of life A 6-item questionnaire across 5 domains: 
mobility, self-care, usual activities, 
pain/discomfort and anxiety/depres-
sion. Each dimension has 5 levels: no 
problems, slight problems, moder-
ate problems, severe problems and 
extreme problems. The questionnaire 
is scored with a 1-digit number that 
expresses the level selected for that 
dimension. The digits for the five 
dimensions can be combined into 
a 5-digit number that describes the 
patient’s health state. The last question 
is a VAS-score (range: 0–100) represent-
ing the patient’s self-rated health with 
100 being ‘The best health you can 
imagine’ and 0 being ‘The worst health 
you can imagine’
x x x
Gallstone Symptom List (GSL) [34] Disease related complaints A 6-item questionnaire. This specific pain 
score was designed and previously 
used in a large cohort of patients in 
the United Kingdom. This question-
naire was designed to asses symptoms 
associated with symptomatic cholecys-
tolithiasis
xa xa xa
EuraHS [33] Disease related complaints A 9-item questionnaire across 3 domains: 
pain, restriction of activities, and cos-
metic discomfort. The questionnaire is 
scored on an 11-point scale from 0–10, 
total score ranges from 0–90 with low 
scores being favourable outcomes
xa xa xa
Knee injury and Osteoarthritis Outcome 
Score (KOOS-PS) [35]
Disease related complaints A 7-item questionnaire about physical 
functioning of patients with knee 
complaints, experienced in the last 
week. The questionnaire is scored on a 
5-points Likert scale (0–4) where 0 is no 
difficulty experienced and 4 is extreme 
difficulty
xa xa xa
Hip disability and Osteoarthritis Out-
come Score (HOOS-PS) [36]
Disease related complaints A 5-item questionnaire about physi-
cal functioning of patients with hip 
complaints, experienced in the last 
week. The questionnaire is scored on a 
5-points Likert scale (0–4) where 0 is no 
difficulty experienced and 4 is extreme 
difficulty
xa xa xa
Short Form Health and Labour Question-
naire (SF-HLQ) [37]
Consequences on employment This questionnaire concerns the 
consequences of health problems 
for employment in a paid job and for 
unpaid work (e.g. household chores). 
These questions pertain to the period 
covering the past month. Health prob-
lems refer both to your physical and 
emotional problems
x x x
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Both direct and indirect medical costs will be consid-
ered. These direct and indirect medical costs include: 
costs of inpatient and outpatient hospital stay, major 
diagnostic and therapeutic procedures, consultations, 
costs of out-of-hospital care by general practitioner and 
allied healthcare providers, non-medical out-of-pocket 
expenses (over-the-counter medication, informal care), 
and indirect non-medical costs of production loss from 
sick leave. These costs will be determined with data from 
the EMR and with data from questionnaires. The EQ-
5D-5L questionnaire will be used at different timepoints 
to generate health status scoring profiles over time, which 
will be transposed into health utilities using country spe-
cific population-based tariffs of time trade-off ratings of 
health states.
Process evaluation
In a process evaluation we will assess facilitators and 
barriers that influence the implementation process and 
adoption of the SDM strategy, making use of existing 
frameworks for the implementation of SDM [44–46]. 
This evaluation will also yield more in-depth informa-
tion about relevant contextual factors and experiences 
of patients and healthcare providers (i.e. physicians and 
nurses) with the SDM strategy in general and with the 
DAs more specific. For this purpose, we will organize 
focus groups with patients and healthcare providers.
Statistical methods
Baseline characteristics will be described using descrip-
tive statistics. If continuous, Student’s t-test will be used 
to calculate differences between clusters for normally 
distributed data. Mann–Whitney U-test will be used for 
skewed data.
Mixed models will be used to analyse the data from the 
stepped-wedge design and to account for clustering of 
patients within hospitals at different follow-up periods. 
We will analyse the effect of the intervention in com-
parison with usual care on the primary outcome surgery 
rates. We will adjust for confounding factors, such as age, 
sex, clinical parameters (e.g. comorbidity), and work-
ing and social activities. Furthermore, we will use mixed 
models to analyse the effect of the SDM strategy regard-
ing the secondary outcomes and to account for clustering 
of repeated measurements within patients and clusters 
of patients within hospitals. In addition, we will include 
time as a covariate in order to investigate time trends. 
When applicable, we will test assumptions of normality 
and linearity, and interaction terms.
Safety monitoring and data access
Data will be captured and stored in an online regis-
try (Castor EDC) during the control phase. During 
intervention phase, answers to questionnaires and in DAs 
will be stored in a second secured environment, which is 
password protected and can only be accessed by investi-
gators. All data will be stored pseudonymized. Locking of 
data and code list will take place after the end of follow‐
up of the last included patient, and data will be stored for 
15 years. Data management will be performed in accord-
ance with FAIR guiding principles [47].
Ethical consideration
The protocol of the study was registered under file 
number 2018-4815 and assessed by the Central Com-
mittee on Research Involving Human Subjects of 
Arnhem-Nijmegen (CCMO Arnhem-Nijmegen). The 
committee confirmed the Medical Research Involving 
Human Subjects Act (WMO) does not apply. Local ethics 
assessment committees of the participating hospitals are 
requested to approve the protocol as well.
Discussion
The results of the E-valuAID will clarify if the implemen-
tation of an SDM strategy with online DAs in surgical- 
and orthopaedic practices reduces surgery rates and is 
cost-effective compared to usual care. This multicentre 
study with a stepped-wedge design will show the effect 
of an SDM strategy on surgery rates, patient-reported 
outcomes, and cost-effectiveness. We hypothesize that 
the application of DAs will result in lower surgery rates, 
while improving patient-reported outcomes.
Rationale of the study design
In the present study we chose a pragmatic approach to 
investigate the effectiveness of SDM with an online DA. 
A recent systematic review shows that the stepped-wedge 
design is particularly used for practical and methodologi-
cal purposes, which makes it well-suited for this study 
[48]. For example, as only a limited number of clinics 
start simultaneously, this design allows a thorough imple-
mentation of the intervention in each clinic. The imple-
mentation protocol requires a dedicated introduction of 
SDM to the users by providing information about the 
study and the online DA. Moreover, the design allows for 
evaluation of both the effect on surgery rates on a hospi-
tal level and outcomes on a patient level. An alternative 
design of a randomized trial on patient-level would have 
the potential pitfall of contamination of usual care by the 
intervention strategy, as it is conceivable that special-
ists transfer their SDM experience and methods to usual 
care. Cluster randomization of departments appeared 
not feasible during the explorative discussions with par-
ticipating hospitals. They strongly preferred to start the 
implementation of the SDM strategy at a predetermined 
moment in time, and our logistic inability to implement 
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randomly decided to refrain from cluster randomization. 
In the present design, the potential risk of selection bias, 
due to clinicians’ decision of not providing an SDM strat-
egy is negligible, as all consecutive patients receive a DA 
before their first consultation.
Current evidence for SDM in surgery
Although the effect of SDM and provision of DAs on 
patient satisfaction are promising [49, 50], there is a 
knowledge gap on the impact of SDM-instruments in 
terms of cost-effectiveness. Up to date, no trials are 
performed to evaluate the cost-effectiveness of DAs in 
patients with an inguinal hernia or gallstones. One study 
evaluated the impact of a DA consisting of a 50 min video 
and a booklet in 343 patients with knee- or hip osteoar-
thritis. This RCT showed DAs were cost-effective, with 
similar health outcomes [51]. Furthermore, Stacey et  al. 
reviewed the literature in 2017, and they included four 
trials with 570 patients with knee or hip osteoarthritis 
[40, 41, 52, 53]. These studies assessed various effects 
of a DA: patient knowledge, the efficiency of decision-
making, or wait times between screening and definitive 
choice, but not on cost-effectiveness. Only our retrospec-
tive evaluation on the effect of online DAs in patients 
with an inguinal hernia or cholecystolithiasis suggested a 
reduction in surgical interventions, but a cost-effective-
ness analysis was lacking [39]. In the absence of existing 
evidence, it is clear that more knowledge on the benefits 
of SDM from patient and societal perspectives is neces-
sary. The E-valuAID aims to solve the current void in the 
literature on the benefits of SDM and online DAs. Results 
of the present study as proposed here, will affect health-
care policy concerning decision-making in surgery for 
the coming decades.
In conclusion, SDM is eminently applicable in patients 
with an inguinal hernia, gallstones, knee- or hip osteoar-
thritis due to both a surgical and conservative treatment 
option. This study will show whether an SDM-strategy 
will lead to a reduced surgery rate and if future imple-
mentation is cost-effective.
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